These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Establishment and experimental study on mouse model of Chlamydia pneumoniae pneumonitis]. Shi Y; Yin J; Zhan H Zhonghua Jie He He Hu Xi Za Zhi; 2001 Oct; 24(10):592-5. PubMed ID: 11770419 [TBL] [Abstract][Full Text] [Related]
12. Experimental rabbit models of Chlamydia pneumoniae infection. Moazed TC; Kuo C; Patton DL; Grayston JT; Campbell LA Am J Pathol; 1996 Feb; 148(2):667-76. PubMed ID: 8579129 [TBL] [Abstract][Full Text] [Related]
13. In vivo treatment of acute Chlamydia pneumoniae infection with the flavonoids quercetin and luteolin and an alkyl gallate, octyl gallate, in a mouse model. Törmäkangas L; Vuorela P; Saario E; Leinonen M; Saikku P; Vuorela H Biochem Pharmacol; 2005 Oct; 70(8):1222-30. PubMed ID: 16139801 [TBL] [Abstract][Full Text] [Related]
14. Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice. Marangoni A; Fiorino E; Gilardi F; Aldini R; Scotti E; Nardini P; Foschi C; Donati M; Montagnani M; Cevenini M; Franco P; Roda A; Crestani M; Cevenini R Atherosclerosis; 2015 Aug; 241(2):471-9. PubMed ID: 26086356 [TBL] [Abstract][Full Text] [Related]
15. Effect of Chlamydia pneumoniae infection and hyperlipidaemia on the expression of PPARgamma, P50 and c-Fos in aortic endothelial cells in C57bL/6J mice. Huang B; Dong Y; Mai W; Li Y Acta Cardiol; 2005 Feb; 60(1):43-9. PubMed ID: 15779851 [TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh model. Tessier PR; Mattoes HM; Dandekar PK; Nightingale CH; Nicolau DP Antimicrob Agents Chemother; 2005 Jan; 49(1):188-94. PubMed ID: 15616295 [TBL] [Abstract][Full Text] [Related]
17. Mouse models of C. pneumoniae infection and atherosclerosis. Campbell LA; Blessing E; Rosenfeld M; Lin Tm; Kuo C J Infect Dis; 2000 Jun; 181 Suppl 3():S508-13. PubMed ID: 10839749 [TBL] [Abstract][Full Text] [Related]
18. A 6 week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with Chlamydia pneumoniae. Blessing E; Campbell LA; Rosenfeld ME; Chesebro B; Kuo CC J Antimicrob Chemother; 2005 Jun; 55(6):1037-40. PubMed ID: 15845780 [TBL] [Abstract][Full Text] [Related]
19. Chlamydia pneumoniae infections augment atherosclerotic lesion formation: a role for serum amyloid P. Ezzahiri R; Stassen FR; Kurvers HR; Dolmans V; Kitslaar PJ; Bruggeman CA APMIS; 2006 Feb; 114(2):117-26. PubMed ID: 16519748 [TBL] [Abstract][Full Text] [Related]
20. [Infection with chlamydia pneumoniae increases oxidative stress and accelerates the development of atherosclerosis in C57BL/6J mice]. Li YQ; Ma H; Dong YG Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):395-8. PubMed ID: 15932691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]